Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart by Chen Che-Hong, Budas Grant R, Churchill Eric N, Disatnik Marie-Hélène, Hurley Thomas D, Mochly-Rosen Daria in Science (New York, N.Y.) (2008).

[PMID: 18787169] PubMed


There is substantial interest in the development of drugs that limit the extent of ischemia-induced cardiac damage caused by myocardial infarction or by certain surgical procedures. Here, using an unbiased proteomic search, we identified mitochondrial aldehyde dehydrogenase 2 (ALDH2) as an enzyme whose activation correlates with reduced ischemic heart damage in rodent models. A high-throughput screen yielded a small-molecule activator of ALDH2 (Alda-1) that, when administered to rats before an ischemic event, reduced infarct size by 60%, most likely through its inhibitory effect on the formation of cytotoxic aldehydes. In vitro, Alda-1 was a particularly effective activator of ALDH2*2, an inactive mutant form of the enzyme that is found in 40% of East Asian populations. Thus, pharmacologic enhancement of ALDH2 activity may be useful for patients with wild-type or mutant ALDH2 who are subjected to cardiac ischemia, such as during coronary bypass surgery.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.